Macquarie Group’s iShares Biotechnology ETF IBB Stock Holding History

Macquarie Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,640	Closed	-$237K	–	1147
2025 Q3	$237K	Buy	1,640 +1,307	+392%	+$178K	﹤0.01%	1474
2025 Q2	$42.1K	Buy	333 +36	+12%	+$4.42K	﹤0.01%	1592
2025 Q1	$38K	Buy	+297	New	+$40.3K	﹤0.01%	1572
2024 Q4	–	Sell	-26,310	Closed	-$3.83M	–	1689
2024 Q3	$3.83M	Buy	26,310 +25,601	+3,611%	+$3.7M	﹤0.01%	1039
2024 Q2	$97.3K	Buy	709 +708	+70,800%	+$94.5K	﹤0.01%	1588
2024 Q1	$0	Buy	+1	New	+$137	﹤0.01%	1917

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Macquarie Group's IBB Position: Q4 2025 in Review

Macquarie Group sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 1,640 shares — an estimated $237K sold.

Macquarie Group first reported a position in IBB in Q1 2024 and held it in 6 quarters. The position peaked at $3.83M in Q3 2024. 958 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

Macquarie Group reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
Macquarie Group sold 1,640 iShares Biotechnology ETF shares in Q4 2025, an estimated $237K.
Macquarie Group first reported a position in iShares Biotechnology ETF in Q1 2024 and held it in 6 quarters.
Macquarie Group's iShares Biotechnology ETF position peaked at $3.83M in Q3 2024.
958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.